CN Patent

CN111201014A — 治疗过度嗜睡的方法和组合物

Assigned to Axum Malta Limited · Expires 2020-05-26 · 6y expired

What this patent protects

本发明涉及氨基甲酰基苯丙氨醇化合物及使用其治疗疾患的方法。本发明进一步涉及开发用于治疗受试者中例如由于发作性睡病或阻塞性睡眠呼吸暂停引起的度嗜睡的方法，其令人惊讶的结果是，基于标准的客观和主观嗜睡测试达到了“正常”水平的清醒度。

USPTO Abstract

本发明涉及氨基甲酰基苯丙氨醇化合物及使用其治疗疾患的方法。本发明进一步涉及开发用于治疗受试者中例如由于发作性睡病或阻塞性睡眠呼吸暂停引起的度嗜睡的方法，其令人惊讶的结果是，基于标准的客观和主观嗜睡测试达到了“正常”水平的清醒度。

Drugs covered by this patent

Patent Metadata

Patent number
CN111201014A
Jurisdiction
CN
Classification
—
Expires
2020-05-26
Drug substance claim
No
Drug product claim
No
Assignee
Axum Malta Limited
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.